Development of hepatitis B virus resistance for lamivudine in a Dutch cohort of HIV-HBV co-infected patients

被引：0
|
作者：
Wolters, LMM [1 ]
Niesters, HGM [1 ]
Brinkman, K [1 ]
Kroon, FP [1 ]
Richter, C [1 ]
Meenhorst, P [1 ]
de Man, RA [1 ]
机构：
[1] Univ Rotterdam Hosp, Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2001年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [31] Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients
    Benhamou, Yves
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (10): : S22 - S25
  • [32] Hepatitis B virus (HBV) mutations associated with lamivudine resistance in human immunodeficiency virus (HIV)-infected patients.
    Thibault, V
    Benhamou, Y
    Seguret, C
    Bocher, M
    Katlama, C
    Bricaire, F
    Opolon, P
    Poynard, T
    Huraux, JM
    HEPATOLOGY, 1998, 28 (04) : 485A - 485A
  • [33] ENTECAVIR MONOTHERAPY SELECTS M184V MUTATION IN LAMIVUDINE-NAiVE AND LAMIVUDINE EXPERIENCED HIV-HBV CO-INFECTED PATIENTS
    Castel, Helene
    Bocket, Laurence
    Tamalet, Catherine
    Bourliere, Marc
    Yazdanpanah, Yazdan
    HEPATOLOGY, 2008, 48 (04) : 728A - 728A
  • [34] Management of hepatitis C in HIV and/or HBV co-infected patients
    Vicente Fernandez-Montero, Jose
    Soriano, Vicente
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (04) : 517 - 530
  • [35] Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada
    Urvi Rana
    Matt Driedger
    Paul Sereda
    Shenyi Pan
    Erin Ding
    Alex Wong
    Sharon Walmsley
    Marina Klein
    Deborah Kelly
    Mona Loutfy
    Rejean Thomas
    Stephen Sanche
    Abigail Kroch
    Nima Machouf
    Marie-Helene Roy-Gagnon
    Robert Hogg
    Curtis L. Cooper
    BMC Infectious Diseases, 19
  • [36] Treatment of hepatitis B virus (HBV) in the setting of HIV-HBV co-infection
    Iser, David M.
    Lewin, Sharon R.
    ASIAN BIOMEDICINE, 2009, 3 (01) : 15 - 27
  • [37] Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada
    Rana, Urvi
    Driedger, Matt
    Sereda, Paul
    Pan, Shenyi
    Ding, Erin
    Wong, Alex
    Walmsley, Sharon
    Klein, Marina
    Kelly, Deborah
    Loutfy, Mona
    Thomas, Rejean
    Sanche, Stephen
    Kroch, Abigail
    Machouf, Nima
    Roy-Gagnon, Marie-Helene
    Hogg, Robert
    Cooper, Curtis L.
    BMC INFECTIOUS DISEASES, 2019, 19 (01)
  • [38] The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients - Reply
    Clumeck, N
    JOURNAL OF HEPATOLOGY, 2005, 43 (02) : 361 - 361
  • [39] Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients
    Fabris, P
    Giordani, MT
    Tositti, G
    Rassu, M
    de Lalla, F
    AIDS, 2003, 17 (10) : 1581 - 1582
  • [40] Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in the Gambia, West Africa
    Stewart B.
    Jobarteh M.L.
    Sarge-Njie R.
    Alabi A.
    De Silva T.
    Peterson K.
    Peterson I.
    Whittle H.
    Rowland-Jones S.
    Jaye A.
    Cotten M.
    Mendy M.
    BMC Research Notes, 4 (1)
12345